Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.21.2
Equity (Tables)
9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of stock options outstanding
Options Outstanding     Options Exercisable  
Range of
Exercise
Price
    Number
Outstanding at
September 30,
2021
    Weighted Average
Remaining
Contractual Life
(Years)
    Weighted
Average
Exercise
Price
    Number
Exercisable at
September 30,
2021
    Weighted
Average
Exercise
Price
 
$ 0.50       2,000,000       5.36     $ 0.50       2,000,000     $ 0.50  
  1.00 – 1.93       2,950,000       4.87       1.39       2,723,334       1.41  
  2.00 – 2.80       2,740,000       2.02       2.17       2,740,000       2.17  
  4.76       30,000       2.51       4.76       30,000       4.76  
$ 0.50 – 4.76       7,720,000       3.97     $ 1.45       7,493,334     $ 1.46  

 

Schedule of stock option activities
    Number of
Options
    Weighted Average
Exercise Price
 
Outstanding at January 1, 2021     7,140,000     $ 1.48  
Granted     660,000       1.10  
Expired     (80,000 )     (1.00 )
Outstanding at September 30, 2021     7,720,000     $ 1.45  
                 
Options exercisable at September 30, 2021     7,493,334     $ 1.46  
Options expected to vest     226,666     $ 1.09  

 

Schedule of company’s nonvested stock options granted
    Number of
Options
    Weighted Average
Exercise Price
 
Nonvested at January 1, 2021     218,334     $ 1.18  
Granted     660,000       1.10  
Vested     (651,668 )     (1.13 )
Nonvested at September 30, 2021     226,666     $ 1.09